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INTRODUCTION
The Nonvariceal Upper Gastrointestinal Bleed-
ing (NVUGIB) is a frequent cause for hospitaliza-
tion(4, 6, 8, 11, 14, 17, 20). Recent clinical studies demonstrate 
that the outcome of  these patients can be improved 
when clinical resources are improved, decreasing the 
recurrence of  bleeding(2, 13, 15, 19), the need for transfu-
sion(13, 19) and surgery(13) and reducing the length of 
stay and hospital costs(13, 19).
A simple measure to enhance the outcome of 
NVUGIB patients could be the improvement of the 
timing when resuming a regular diet. There was a 
traditional idea that fasting could reduce gastric secre-
tion, and thus could be useful as an adjuvant measure 
to heal ulcers and other bleeding lesions. This, how-
ever, has never been proved. On the contrary, a 2003 
study addressed the question of the potential secretory 
stimulus of  oral feeding in NVUGIB patients and 
found that gastric secretion of  patients under anti-
secretory drugs was scarcely affected by feeding(16). 
Although there are only a few published studies on 
the subject of  resuming oral feeding of  NVUGIB 
patients, not a single advises fasting. More than 20 
years ago, a prospective randomized study compared 
two groups, one receiving a regular diet immediately 
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after bleeding, and other group receiving no oral 
nutrition for 36 hours, followed by clear liquids for 
12 hours, and a regular diet thereafter. In this study 
refeeding protocol did not influenced the patient’s 
hospital course(10). Two more recent randomized stud-
ies proved that early feeding did not worsen outcome 
and furthermore enables early discharge and reduces 
the costs of treatment(5, 9). Disregarding the available 
evidence, scientific societies of gastroenterologists and 
other professionals dealing with NVUGIB rarely ad-
dress the question of restarting feeding of NVUGIB 
patients. Nevertheless, some guidelines recommend an 
early refeeding. The 2003 consensus, promoted by the 
Canadian Association of Gastroenterology, suggests 
immediate oral feeding in patients with low risk ulcers 
and Mallory-Weiss tears(1). Also, the guidelines from 
the British Society of Gastroenterology Endoscopy 
Committee suggest the introduction of liquid diet 4 to 
6 hours after endoscopy with or without a therapeutic 
procedure(3). Generally, it is consensual that patients 
with low risk lesions should resume oral intake im-
mediately, and those with high risk lesions should 
probably be refed a short period after endoscopy.
To the best of our knowledge, there are few sys-
tematic studies on refeeding after a NVUGIB episode. 
There is a subjective awareness that nutrition of 
Fonseca J, Meira T, Nunes A, Santos CA. Bleeding and starving: fasting and delayed refeeding after upper gastrointestinal bleeding
v. 51 no. 2 - abr./jun. 2014  Arq Gastroenterol 129
NVUGIB patients is largely overlooked in many hospitals. 
The major aim of this retrospective study was obtaining ob-
jective data on refeeding patients after a NVUGIB episode, 
in the real live context of a Portuguese large hospital. The 
specific aims were:
1. After a NVUGIB episode, evaluate the time span until 
resuming oral intake.
2. Evaluate the differences of feeding management be-
tween patients and bleeding lesions with high and low 
rebleeding risk.
3. Evaluate the quality of clinical records on refeeding 
after NVUGIB episode.
METHODS
From the records of  upper gastrointestinal (GI) endos-
copy, we selected all the patients that underwent urgent 
endoscopy for NVUGIB since January, 1st to December, 
31st of  2008. Once the patients were identified through 
the index endoscopy, the clinical files of  the episode were 
evaluated. This particular year was chosen because it was 
the last year in which most hospital data was recorded in 
paper files.
As a rule, every upper GI bleeding patient is submitted 
to urgent endoscopy in the admission day. For the purpose 
of the present study the day of the index endoscopy was day 
one. From the clinical files, we collected:
1. Clinical features of  the patients and the NVUGIB 
episodes.
2. Severity of the NVUGIB episodes, using the Rockall 
score(18).
3. Endoscopic data including:
a. Endoscopic diagnosis.
b. Severity of the lesions according with Forrest clas-
sification(7) Lesions classified as Forrest Ia, Ib and 
IIa were labeled as high risk lesions.
c. Use of endoscopic therapy.
4. Feeding related records of the first seven days in the 
hospital, including:
a. Record of prescription of liquid diet.
b. Record of first liquid intake.
c. Record of prescription of soft/solid diet.
d. Record of first soft/solid intake.
Patients previously hospitalized (in-hospital upper GI 
bleeding) and patients with hospital stay shorter than 24 
hours were excluded.
Results are presented as descriptive statistics using the 
Excel software. The statistical analysis was performed with 
the Statistical Package for Social Sciences (SPSS, version 
20.0). All statistical tests were performed at the 5% level of 
significance. Independent Sample t-test was used to assess 
the differences of  refeeding days between groups with or 
without endoscopic therapy and between groups with low or 
high Rockall score. For equality of variances, the Levene’s 
test was used.
RESULTS
From the urgent upper GI endoscopy files we selected 175 
patients with a NVUGIB episode. Forty-two were excluded 
because hospital stay was shorter than 24 hours.We identified 
files from 133 patients with a NVUGIB episode longer than 
24 hours, with a mean age of 71 years, 84 (63%) men and 
49 women. Records from 126 patients allowed classification 
according Rockall score, 76 (60%) having a clinically severe 
(score ≥ 5) bleeding episode and 50 (40%) having a mild 
episode. One case presented a persistent bleeding after the 
index endoscopy, and underwent surgery. Only eight cases 
suffered a rebleeding episode (two presenting Rockall < 5 and 
six with Rockall ≥ 5) and one of these severe cases needed 
surgery to control the rebleeding episode. Thirteen patients 
died within thirty days following the NVUGIB episode, all of 
them after the 7th day of hospitalization. These included the 
two cases that underwent surgery for the initial NVUGIB and 
for a rebleeding episode. The remaining 11 deceased patients 
died from causes not directly related with the hemorrhage: 
cardiovascular (4), renal (2), hepatic (2) or respiratory (1) 
failure, or sepsis (2 patients).
All patients were subject to urgent endoscopy. Identify-
ing the bleeding lesions was possible in most of them. Only 
11 cases had no lesion found, although 7 out of  these 11 
presented blood in the stomach and were considered to be 
inconclusive (Table 1). Ulcer, gastric or duodenal, was the 
most frequent cause of bleeding, accounting for 62% of the 
cases. Almost half, 37 patients, presented ulcers with high risk 
stigmata, Forrest Ia, Ib and IIa lesions. Endoscopic therapy 
was performed in 63 (47%) patients, including all patients 
presenting high risk ulcers and other high risk lesions.
TABLE 1. Endoscopic diagnosis
Diagnosis n %
Duodenal ulcer 42 31.6
Gastric ulcer 40 30
Erosive gastritis/duodenitis 9 6.8
Neoplasia 5 3.8
Oesophagitis 6 4.5
Angiodysplasia 8 6
Dieulafoy ulcer 5 3.8
Mallory-Weiss 3 2.3
Barrett’s oesophagus 2 1.5
Polyps 1 0.8
Hiatal hernia ulcer 1 0.8
Blood in the stomach 7 5.3
No blood or lesion 4 3
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Searching for the refeeding records, there were 142 out 
of the 532 possible and appropriate:
- 53 prescriptions of liquid diet,
- 51 records of first liquid intake,
- 18 prescription of soft/solid diet, and
- 20 records of soft/solid diet intake.
Only 84 patient files out of  133 (63%) had some type 
of  refeeding record and only three files presented all four 
records (Table 2).
TABLE 2. Number of refeeding records of each patient
Number of refeeding records Number of patients %
0 49 37
1 41 31
2 31 23
3 9 7
4 3 2
Using the first record, prescription or oral intake, as the 
first oral feeding day, we estimated that oral refeeding started 
at the first day in only 14% of patients, at the second day in 
36%, at the third day in 30%, at the fourth day 8% and 12% 
of patients at the fifth day or later.
From these 84 patients, it was possible to achieve a 
Rockall classification in 81. By splitting them according to 
the Rockall score, we found 30 patients with mild bleeding 
episodes (score < 5) and a median refeeding on day 2, and 
51 with severe bleeding episodes (score ≥ 5) and a median 
refeeding on day 3. This difference is not statistically signifi-
cant (P = 0.297) (Figure 1).
median refeeding on day 2, and 50 without therapy displayed 
a median refeeding on day 3. This difference is not statisti-
cally significant (P = 0.430) (Figure 2).
FIGURE 1. Refeeding day according with Rockall severity score
We additionally split these 84 patients according to pres-
ence or absence of endoscopic therapy, a surrogate marker 
for the severity of lesions found at the index endoscopy. The 
34 patients that underwent endoscopic therapy displayed a 
FIGURE 2. Refeeding day according with endoscopic therapy
Reviewing the clinical files of the patients that underwent 
a rebleeding episode, we verified that all of them, including 
the one that needed surgery, resumed oral intake before the 
rebleeding episode, and thus this adverse outcome did not 
interfere with the nutritional decisions. In addition, the pa-
tient that underwent surgery for the initial NVUGIB was tube 
fed before dying from a surgery complication. All the other 
11 deceased patients that passed away from non-bleeding 
conditions were orally or tube fed during the hospitaliza-
tion. Refeeding records from all these patients with adverse 
outcomes (persistent bleeding, rebleeding, surgery or death) 
were collected and evaluated with the same methodology as 
data from patients with better outcome.
DISCUSSION
In the recent years, NVUGIB outcomes have been im-
proved as result of the introduction and spreading of new 
therapeutic approaches, both pharmacological and endo-
scopic. Nevertheless, there is still some significant mortality 
associated with NVUGIB episodes(13, 19). A recent internation-
al, multicentric, pan-European study revealed that, despite 
some variations, clinical management of NVUGIB is similar 
throughout 123 Hospitals across all Europe(12). Management 
of NVUGIB was also similar at the 12 Portuguese centers 
enrolled in this European study(6). Having achieved an high 
standard on pharmacological and endoscopic approaches, 
teams taking care of NVUGIB patients must improve other 
aspects of management, namely organizational issues(6). Nu-
tritional approach is surely one of those issues. It has been 
evidenced that early refeeding is safe(10, 16) and may reduce 
hospital stay and treatment costs(5, 9). It is recommended by 
the guidelines(1, 3). Nevertheless, nutrition of NVUGIB pa-
tients seems to be undervalued in every-day clinical practice.
The aim of the present study was to obtain objective data 
on refeeding patients after a NVUGIB episode in a real live 
practice, but it has some limitations. One of them was the 
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focus on the year 2008 instead of a later year, but we believe 
that there is no major change in the clinical practice. More-
over, in later years, nutritional records could be even lower or 
scattered between paper and several computer clinical data 
bases. Some patients that had mild NVUGIB with a hospital 
stay shorter than 24 hours were excluded. Conversely, as the 
bleeding episodes were looked after through an index emer-
gence endoscopy, patients with very severe NVUGIB might 
have been submitted to emergence surgery without previous 
endoscopy, failing inclusion. This is an unlikely case but 
not an impossible one. Hence some patients with very mild 
or very severe NVUGIB may have been excluded from the 
study. Finally, the evaluation is based on the recorded data, 
which proved to be very poor, but these are the limitations 
of a retrospective, “real life” study, and the lack of records 
is also important information.
One of the aims of the present study was the evaluation 
of the quality of clinical records on refeeding after NVUGIB 
episode. We found 142 out of  532 (27%) of  the intended 
refeeding records of  133 patients. Moreover, 37% did not 
have any record, but we believe that 1/3 of our patients had 
not been fasting during one week, some of which until the 
discharge. There is poor recording of feeding data and, as 
far as we can see, this reflects insufficient attention paid to 
nutritional issues.
Another aim of this study was evaluating the time span 
until oral intake was resumed, following a NVUGIB episode. 
Our available data points towards only 16% of patients being 
fed at first day. Half  of the patients resumed oral intake at 
the third day or later. More than a half  of the patients (53%) 
presented low risk lesions and was not submitted to any kind 
of endoscopic treatment. These patients should have started 
oral feeding in Day 1.
Focusing on the 84 patients with feeding records, it was 
possible to achieve a Rockall classification in 81 of them. The 
30 patients with Rockall score < 5 (mild) display a median 
refeeding on day 2, sooner than the 51 with Rockall score 
≥ 5 (severe), which presented a median refeeding on day 3. 
As expected, those who were clinically more unstable restart 
oral nutrition after a larger interval.
Splitting these 84 patients according to the index endos-
copy, the 34 that underwent endoscopic therapy presented 
a median refeeding on day 2, which seems satisfactory. 
Resuming oral intake on Day 2 indicates that the first meal 
is provided around 24 hours after endoscopic intervention. 
Resuming oral diet could have probably been sooner in some 
patients, but a 24-hour delay is acceptable for endoscopi-
cally treated patients with high risk lesions. Conversely, the 
other 50 patients without endoscopic therapy displayed a 
median refeeding on day 3, which is clearly inadequate. 
Patients with low risk lesions that did not undergo endo-
scopic treatment should start oral nutrition immediately 
after recovering from the urgent endoscopy. The finding of 
a later refeeding in non-treated patients, when compared 
to the endoscopically treated ones, is a paradox and chal-
lenging to explain. This cannot be a matter of  poor written 
information of  patients with low risk lesions. Looking at all 
the 133 patients, feeding records were present in 34 of  the 
63 patients that underwent endoscopic therapy (54%), and 
in 50 of  the 70 (71%) who did not underwent such therapy. 
Patients without high risk lesions do not present feeding 
records less frequently, which indicated that this may not 
be a problem of  lack of  data. A possible explanation may 
be that patients with milder lesions inspire less concern, get 
less attention, and are refed later than those with high risk 
lesions and endoscopic therapy.
Globally, available data points towards a late restart of 
oral feeding for most of NVUGIB patients. For some patients 
that presented high risk endoscopic lesions and/or endoscopic 
therapy, refeeding timing may be accurate or near accurate, 
but concerning the patients with low risk lesions delayed 
refeeding was clearly inadequate.
CONCLUSIONS
The present study confirms that nutritional issues are un-
dervalued in the clinical management of NVUGIB patients. 
Most desirable feeding records were missing and circa one 
third of all the patients presented no nutritional data from 
the first week after the bleeding. The available data reveals 
that refeeding is clearly delayed. Major delay is evident in 
patients with low risk endoscopic lesions who should be fed 
immediately after the urgent endoscopy. Teams taking care 
of NVUGIB patients must be aware of the advantages of 
early oral nutrition of these patients, and should follow the 
available international guidelines and recommendations.
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